Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Nasus Pharma Ltd.

Nasus Pharma Ltd. (NSRX) Stock Overview

Explore Nasus Pharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

NSRX●AMEX
HealthcareMedical - Pharmaceuticals
$4.00
$0.15(3.90%)
U.S. Market opens in NaNh NaNm

Nasus Pharma Ltd. (NSRX)

Meyka AI Score

Z

Key Financials

Market Cap34.5M
P/E Ratio-23.41
EPS (TTM)$-0.72
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$2.96
3 Months$2.42
1 Year Target$2.49

NSRX Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of Nasus Pharma Ltd. (AMEX: NSRX) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Nasus Pharma Ltd.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NSRX on the AMEX shows an RSI of 70.04, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $2.49 for the AMEX listing.

Key metrics behind Nasus Pharma Ltd.'s AMEX-traded stock include a P/E ratio of -23.41 and a market capitalization of 34.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of NSRX on the AMEX.

Price Performance (AMEX: NSRX)

1-Day Change
3.90%
5-Day Change
25.00%
1-Month Change
32.01%
3-Month Change
39.37%
6-Month Change
-32.20%
Year-to-Date (YTD) Change
-56.28%
1-Year Change
-52.94%
3-Year Change
-51.52%
5-Year Change
-51.52%
All-Time (Max) Change
-51.52%

Contact Information

https://www.nasuspharma.com
97235736632
Yigal Alon 65, Tel Aviv, TA, 6744317

Company Facts

70 Employees
IPO DateAug 13, 2025
CountryIL
Actively Trading

Frequently Asked Questions